ARCLIZON, created in 2006 (United States), from 16 sister brands and 2214 competing brands. ARCLIZON is a brand of Regeneron Pharmaceuticals, listed on the stock exchange of New York. ARCLIZON belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Regeneron Pharmaceuticals
(ARCLIZON)
over 5 years*
USD 2,353.80